Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1; this appears to be a minor internal update with no visible changes to study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check13 days agoChange DetectedThe Publications section now clarifies that entries are automatically filled from PubMed and may not all pertain to the study, and a Revision: v3.3.1 tag was added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the global government funding/operating status notice from the page, a general site-wide message not related to the study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check35 days agoChange DetectedOnly minor layout and formatting adjustments were observed on the Study Details page, with core study data such as inclusion criteria, primary outcomes, and enrollment remaining unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check64 days agoChange DetectedUpdated the page to v3.2.0 and added a government-status notice about operations and funding, replacing the previous v3.1.0 tag.SummaryDifference3%

- Check71 days agoChange Detected- Added: Revision: v3.1.0. - Removed: “Genetic and Rare Diseases Information Center resources: Ovarian cancer” and old revision tag “Revision: v3.0.2.”SummaryDifference0.4%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.